Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect

被引:9
作者
Heo, Moonseong [1 ]
Meissner, Paul [2 ]
Litwin, Alain H. [3 ]
Arnsten, Julia H. [3 ]
McKee, M. Diane [2 ]
Karasz, Alison [2 ]
McKinley, Paula [3 ]
Rehm, Colin D. [1 ,4 ]
Chambers, Earle C. [2 ]
Yeh, Ming-Chin [5 ]
Wylie-Rosett, Judith [1 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family & Social Med, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, Off Community & Populat Hlth, 111 E 210th St, Bronx, NY 10467 USA
[5] CUNY Hunter Coll, Nutr Program, New York, NY 10021 USA
关键词
Preference; comparative effectiveness research; power; decision making; randomization; DIABETES-PREVENTION-PROGRAM; DIRECTLY OBSERVED THERAPY; LIFE-STYLE INTERVENTION; HEPATITIS-C VIRUS; TRIALS; MANAGEMENT; REDUCTION; COMMUNITY; OUTCOMES; CONSENT;
D O I
10.1177/0962280217734584
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Comparative effectiveness research trials in real-world settings may require participants to choose between preferred intervention options. A randomized clinical trial with parallel experimental and control arms is straightforward and regarded as a gold standard design, but by design it forces and anticipates the participants to comply with a randomly assigned intervention regardless of their preference. Therefore, the randomized clinical trial may impose impractical limitations when planning comparative effectiveness research trials. To accommodate participants' preference if they are expressed, and to maintain randomization, we propose an alternative design that allows participants' preference after randomization, which we call a "preference option randomized design (PORD)". In contrast to other preference designs, which ask whether or not participants consent to the assigned intervention after randomization, the crucial feature of preference option randomized design is its unique informed consent process before randomization. Specifically, the preference option randomized design consent process informs participants that they can opt out and switch to the other intervention only if after randomization they actively express the desire to do so. Participants who do not independently express explicit alternate preference or assent to the randomly assigned intervention are considered to not have an alternate preference. In sum, preference option randomized design intends to maximize retention, minimize possibility of forced assignment for any participants, and to maintain randomization by allowing participants with no or equal preference to represent random assignments. This design scheme enables to define five effects that are interconnected with each other through common design parameters-comparative, preference, selection, intent-to-treat, and overall/as-treated-to collectively guide decision making between interventions. Statistical power functions for testing all these effects are derived, and simulations verified the validity of the power functions under normal and binomial distributions.
引用
收藏
页码:626 / 640
页数:15
相关论文
共 31 条
  • [1] Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community - The YMCA model
    Ackermann, Ronald T.
    Marrero, David G.
    [J]. DIABETES EDUCATOR, 2007, 33 (01) : 69 - +
  • [2] Translating the Diabetes Prevention Program into the community - The DEPLOY pilot study
    Ackermann, Ronald T.
    Finch, Emily A.
    Brizendine, Edward
    Zhou, Honghong
    Marrero, David G.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2008, 35 (04) : 357 - 363
  • [3] Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629
  • [4] [Anonymous], BR MED J
  • [5] [Anonymous], BMC HLTH SERV RES
  • [6] Effect of Directly Observed Therapy for Highly Active Antiretroviral Therapy on Virologic, Immunologic, and Adherence Outcomes: A Meta-Analysis and Systematic Review
    Arnsten, Julia H.
    Litwin, Alain H.
    Berg, Karina M.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (01) : E33 - E34
  • [7] Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial
    Berg, Karina M.
    Litwin, Alain
    Li, Xuan
    Heo, Moonseong
    Arnsten, Julia H.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2011, 113 (2-3) : 192 - 199
  • [8] Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit All
    Bruggmann, Philip
    Litwin, Alain H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 : S56 - S61
  • [9] Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease
    Chen, Fang
    Su, Wenqing
    Becker, Shawn H.
    Payne, Mike
    Sweet, Cynthia M. Castro
    Peters, Anne L.
    Dall, Timothy M.
    [J]. PLOS ONE, 2016, 11 (10):
  • [10] Concato J, 2010, J INVEST MED, V58, P764, DOI 10.231/JIM.0b013e3181e3d2af